Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself?  Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*